(Q46598397)

English

Capecitabine-warfarin interaction

scientific article published on 12 July 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

Capecitabine-warfarin interaction (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

author name string

Laurel M Janney

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

Nancee V Waterbury

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

language of work or name

0 references

publication date

12 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

Annals of Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

39

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

1546-1551

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G153

21 January 2018

Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first-line treatment in metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G153

21 January 2018

A method for estimating the probability of adverse drug reactions

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G153

21 January 2018

Clinical pharmacokinetics of capecitabine

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G153

21 January 2018

An adverse interaction between warfarin and capecitabine: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G153

21 January 2018

Capecitabine-induced potentiation of warfarin

1 reference

https://api.crossref.org/works/10.1345%2FAPH.1G153

21 January 2018

Identifiers

10.1345/APH.1G153

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16014372

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46598397&oldid=2121348760"